The government is trying to understand the regulatory, technical and market-related challenges that are likely to crop up in getting a manufacturer to produce a vaccine developed elsewhere.Two executives at two covid vaccine developers say it is relatively easier for companies to just fill and package finished vaccines produced by the original manufacturer than manufacture it

from Livemint - News https://ift.tt/2D2p337
https://ift.tt/eA8V8J

Post a Comment

Previous Post Next Post